AstraZeneca Subsidiaries & Acquisitions

  • November 14, 2024

AstraZeneca has broadened its impact through key acquisitions in oncology, rare diseases, and respiratory care, notably with Alexion Pharmaceuticals and MedImmune. These additions have strengthened its research and expanded its ability to address major health challenges with innovative treatments.

Notable Acquisitions of AstraZeneca

  1. Alexion Pharmaceuticals – December 12, 2020: Specializes in rare disease therapies and complement biology.
  2. MedImmune – April 14, 2007: Focused on biologics, vaccines, and immunotherapy.
  3. Cambridge Antibody Technology – May 18, 2006: Pioneered antibody discovery and development.
  4. Neogene Therapeutics – November 29, 2022: Develops T-cell receptor therapies for solid tumors.
  5. Gracell Biotechnologies – February 22, 2024: Innovates in CAR-T cell therapies for oncology and autoimmune conditions.
  6. Fusion Pharmaceuticals – March 19, 2024: Develops radioconjugates for targeted cancer treatments.
  7. CinCor Pharma – January 9, 2023: Focuses on cardiovascular treatments, especially for hypertension.
  8. Almirall – July 30, 2014: Offers expertise in respiratory and dermatological treatments.
  9. Pearl Therapeutics – June 10, 2013: Specializes in inhalation therapies for respiratory diseases.
  10. Ardea Biosciences – April 23, 2012: Known for treatments targeting gout and related diseases.

List of AstraZeneca Acquisitions

S. No.Acquiree NameAnnounced DatePrice
1Fusion PharmaceuticalsMar 19, 2024$2.4B
2Amolyt PharmaMar 14, 2024$1.1B
3Gracell BiotechnologiesFeb 22, 2024—
4IcosavaxDec 12, 2023$1.1B
5Cincor PharmaJan 09, 2023$1.8B
6Neogene TherapeuticsNov 29, 2022$320M
7TeneotwoJul 05, 2022$100M
8Caelum BiosciencesSep 29, 2021$500M
9Alexion PharmaceuticalsDec 12, 2020$39B
10Takeda Respiratory BusinessApr 16, 2016$575M
11AcertapharmaDec 17, 2015$4B
12Zs PharmaNov 06, 2015$2.7B
13AlmirallJul 30, 2014—
14Pearl TherapeuticsJun 10, 2013$1.2B
15Omthera PharmaceuticalsMay 29, 2013$323M
16Ardea BiosciencesApr 23, 2012$781M
17Guangdong Beikang Pharmaceutical Company LtdDec 08, 2011—
18NovexelDec 23, 2009—
19MedimmuneApr 14, 2007$15.6B
20Arrow TherapeuticsFeb 01, 2007$150M
21Cambridge Antibody TechnologyMay 18, 2006$567M
22Kudos Pharmaceuticals LtdDec 23, 2005$210M

List of AstraZeneca Subsidiaries

AstraZeneca has more than 250+ subsidiaries. The table contains the 100 subsidiaries of AstraZeneca –

S. No.SubsidiariesCountry
1Ardea Biosciences IncUnited States
2Amylin Ohio LlcUnited States
3Amylin Pharmaceuticals LlcUnited States
4Astrazeneca Collaboration Ventures LlcUnited States
5Astrazeneca Finance LlcUnited States
6Astrazeneca Finance And Holdings IncUnited States
7Astrazeneca Pharmaceuticals LpUnited States
8Atkemix Nine IncUnited States
9Atkemix Ten IncUnited States
10Bms Holdco IncUnited States
11Cincor Pharma IncUnited States
12Corpus Christi Holdings IncUnited States
13Isochrone Merger Sub IncUnited States
14Neogene Therapeutics IncUnited States
15Omthera Pharmaceuticals IncUnited States
16Optein IncUnited States
17Stauffer Management Company LlcUnited States
18Zeneca Holdings IncUnited States
19Zeneca IncUnited States
20Zeneca Wilmington IncUnited States
21Zs Pharma IncUnited States
22Alphacore Pharma LlcUnited States
23Az-Mont Insurance CompanyUnited States
24Medimmune LlcUnited States
25Medimmune Ventures IncUnited States
26Pearl Therapeutics IncUnited States
27Caelum Biosciences IncUnited States
28Alexion Services Latin America IncUnited States
29Portola Usa IncUnited States
30Portola Pharmaceuticals LlcUnited States
31Achillion Pharmaceuticals IncUnited States
32Alexion Delaware Holding LlcUnited States
33Alexion Pharma LlcUnited States
34Alexion Pharmaceuticals IncUnited States
35Alexion Us1 LlcUnited States
36Alexion Us Holdings LlcUnited States
37Logicbio Therapeutics IncUnited States
38Savoy Therapeutics CorpUnited States
39Syntimmune IncUnited States
40Teneotwo IncUnited States
41Acerta Pharma Llc7United States
42Logicbio Securities CorporationUnited States
43Alexion Holding LlcUnited States
44Astrazeneca Pharmaceutical Co LimitedChina
45Astrazeneca (Wuxi) Trading Co LtdChina
46Astrazeneca Investment (China) Co LtdChina
47Astrazeneca Pharmaceutical (China) Co LtdChina
48Astrazeneca Pharmaceutical (Beijing) Co LtdChina
49Astrazeneca (Guangzhou) Pharmaceutical Co LtdChina
50Astrazeneca Investment Consulting (Wuxi) Co LtdChina
51Astrazeneca Pharmaceutical (Hangzhou) Co LtdChina
52Astrazeneca Global R&D (China) Co LtdChina
53Astrazeneca Pharmaceutical (Chengdu) Co LtdChina
54Astrazeneca Pharmaceutical (Shanghai) Co LtdChina
55Alexion Pharmaceuticals (Shanghai) Company LimitedChina
56Astrazeneca Pharmaceutical Manufacturing (Qingdao) Co LtdChina
57Astrazeneca Pharmaceutical (Qingdao) Co LtdChina
58Ardea Biosciences LimitedUnited Kingdom
59Arrow Therapeutics LimitedUnited Kingdom
60Astra Pharmaceuticals LimitedUnited Kingdom
61AstrapharmUnited Kingdom
62Astrazeneca China Uk LimitedUnited Kingdom
63Astrazeneca Death In Service Trustee LimitedUnited Kingdom
64Astrazeneca Employee Share Trust LimitedUnited Kingdom
65Astrazeneca Finance LimitedUnited Kingdom
66Astrazeneca Intermediate Holdings LimitedUnited Kingdom
67Astrazeneca Investments LimitedUnited Kingdom
68Astrazeneca Japan LimitedUnited Kingdom
69Astrazeneca Nominees LimitedUnited Kingdom
70Astrazeneca Quest LimitedUnited Kingdom
71Astrazeneca Share Trust LimitedUnited Kingdom
72Astrazeneca Sweden Investments LimitedUnited Kingdom
73Astrazeneca Treasury LimitedUnited Kingdom
74Astrazeneca Uk LimitedUnited Kingdom
75Astrazeneca Us Investments LimitedUnited Kingdom
76Azenco2 LimitedUnited Kingdom
77Azenco4 LimitedUnited Kingdom
78Cambridge Antibody Technology Group LimitedUnited Kingdom
79Kudos Horsham LimitedUnited Kingdom
80Kudos Pharmaceuticals LimitedUnited Kingdom
81Zenco (No 8) LimitedUnited Kingdom
82Zeneca Finance (Netherlands) CompanyUnited Kingdom
83Medimmune LimitedUnited Kingdom
84Medimmune Uk LimitedUnited Kingdom
85Syntimmune LimitedUnited Kingdom
86Alexion Pharma Uk LimitedUnited Kingdom
87Portola Pharma Uk Limited (In Liquidation)United Kingdom
88Astrazeneca Holdings Pty LimitedAustralia
89Astrazeneca Pty LimitedAustralia
90Alexion Pharmaceuticals Australasia Pty LtdAustralia
91Logicbio Australia Pty LimitedAustralia
92Aapm SarlAlgeria
93Astrazeneca SaArgentina
94Alexion Pharma Argentina SrlArgentina
95Astrazeneca Österreich GmbhAustria
96Alexion Pharma Austria GmbhAustria
97Portola Österreich GmbhAustria
98Astrazeneca Sa / NvBelgium
99Alexion Pharma Belgium SprlBelgium
100Alexion Services Europe SprlBelgium

Table of Content

Insights you may find interesting

Related Articles

Dow Subsidiaries & Acquisitions

Dow has expanded its reach across various industries through a focused strategy of acquisitions and subsidiary development. By acquiring materials science, chemical production, and plastics companies, Dow has broadened its expertise and product range, allowing it to better respond to market needs. This approach has strengthened Dow’s position across multiple

Read More »

Mondelez International Subsidiaries & Acquisitions

Mondelez International has expanded its reach with acquisitions in confectionery, health snacks, and beverages. These strategic moves enable Mondelez to meet evolving consumer demands and strengthen its position as a leader in the global snack market. Notable Acquisitions of Mondelez International List of Mondelez International Acquisitions S. No. Acquiree Name

Read More »

Accenture Subsidiaries & Acquisitions

Accenture has expanded its industry reach through acquisitions in areas like digital transformation, cybersecurity, cloud services, and AI. These targeted moves have strengthened Accenture’s capabilities and leadership in delivering effective solutions. This article highlights key acquisitions and their role in the company’s growth across sectors. Notable Acquisitions of Accenture List

Read More »
Topics:

Was this article helpful?

Yes No

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.